The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy

Lidija Mikic1, Arsen Ristic2,3, Natasa Markovic Nikolic1,3

  • 1Division of Cardiology, Clinical and Hospital Center Zvezdara, 11120 Belgrade, Serbia.

PubMed

Insights

Cardiopulmonary exercise testing (CPET) offers a comprehensive evaluation for hypertrophic cardiomyopathy (HCM) patients, assessing disease severity and guiding treatment decisions. This advanced method improves risk stratification and therapy monitoring for better patient outcomes.

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Hypertrophic cardiomyopathy (HCM) presents diagnostic challenges with standard exercise tests.
  • ECG changes and wall motion abnormalities limit traditional assessments in HCM patients.

Purpose of the Study:

  • To highlight the critical role of cardiopulmonary exercise testing (CPET) in managing hypertrophic cardiomyopathy (HCM).
  • To underscore CPET's utility in assessing disease severity, functional limitations, and risk stratification in HCM.

Main Methods:

  • Cardiopulmonary exercise testing (CPET) for comprehensive physiological assessment.
  • Integration of CPET with echocardiography (CPET imaging) and invasive methods for enhanced evaluation.

Main Results:

  • CPET provides superior assessment of pathophysiology, functional capacity, and exercise-induced abnormalities in HCM.
  • CPET aids in risk stratification for sudden cardiac death and guides decisions for advanced therapies like CRT and transplantation.
  • CPET assists in differentiating HCM from other cardiac conditions and informs exercise prescription.

Conclusions:

  • CPET is an invaluable tool for risk stratification, guiding therapy, and monitoring patients with HCM.
  • Regular CPET (annually or biannually) is recommended for optimal management of HCM patients.
  • Specialized CPET protocols, including imaging and invasive techniques, offer deeper insights into HCM pathophysiology during exercise.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
272
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15